Combating HIV with Early Detection: The Expansion of the HIV Diagnosis Market

1. Rising Incidence of HIVs Propels Requirement for HIV Diagnosis 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The HIV diagnosis industry is projected to generate $4.13 billion in 2021, rising at a rate of 9.7% from 2021-2030, to capture $9.55 billion revenue in 2030. The rising prevalence of AIDS, led by increasing transfusions, and blood donations fuel the demand for HIV diagnosis. There are majorly three types of HIV tests: Antigen/antibody tests, antibody tests, and nucleic acid tests (NAT). Antibody tests detect HIV to identify HIV in a person’s blood or oral fluid. The antibody test scan takes 23 to 90 days for the detection of HIV after exposure. Antibody testing involves blood usage from a vein that can soon detect HIV, after injecting tests with blood from a finger stick or oral fluid. Antigen tests involve looking for both antigens and HIV antibodies. A person’s immune system produces antibodies when they are exposed to HIV viruses. Antigens are considered foreign substances that affect an individual’s immune system. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/hiv-diagnosis- market/report-sample NAT involves looking for the actual virus in the blood. This test is usually recommended for people with recent exposure or possible exposure to early HIV symptoms. This test can detect HIV in 10 to 33 days after exposure. An HIV-infected person produces a p24 antigen to develop antibodies. An antigen/antibody test is usually performed in the lab on vein blood that can detect HIV in 18 to 45 days after exposure. There is quick availability of finger stick antigen/ antibody tests. Additionally, point-of-care kits and instrument advantages are projected to fuel the industry's growth. AIDS virus can be spread through infected blood transfusion, or compromised needles to a healthy individual. The government associations' participation in educational programs has resulted in growing awareness of worldwide unsafe blood transfusion and blood donations. The point-of-care kits and instruments are projected to fuel the industry growth in the coming years. Inquire before purchase@ https://www.psmarketresearch.com/send- enquiry?enquiry-url=hiv-diagnosis-market Several associations of WHO including Red Crescent Societies, the American Red 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. Cross, and the International Federation of Red Cross support blood donation programs and are aware of people to safely donate blood and blood components. The unsterilized needles usage during blood transfusion results in high infection risk, and thus fuels the industry's growth. In addition, the rising awareness of increasing blood transfusions and blood donations is projected to result in a growing prevalence of HIV infection, which boost the industry growth. The emergence of point-of-care instruments and kits for infection detection leads to an increased rate of diagnosis. The pint-of-care instruments and kits are convenient, affordable, and time- saving, and provide high-confirmatory testing. Moreover, the instruments and kits provide offer easy-to-perform medical tests at the point of care or bedside. The rising usage of these devices by HIV-infected individuals and cautious people boosts the industry's growth in the coming future. Over the last few years, the increasing healthcare expenditure in numerous countries has reduced the AIDS burden, more specifically in low- and middle- income countries. The rising awareness on blood donations propel requirement for HIV diagnosis. The research offers market size of the global HIV diagnosis market for the period 2017–2030. Market Segmentation by Product Consumables • oAssays, Kits & Reagents oOthers Instruments Software & Services Market Segmentation by Type of Test Antibody Test • • • oHIV-1 Screening Test Elisa Rapid Test Home Access Dried Blood Spot ▪ ▪ ▪ oHIV-1 Antibody Confirmatory Test Western Blot ▪ 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. Indirect Immune Fluorescent Antibody Assays (IFA) Line Immunoassays (LIA) Radio-Immunoprecipitation Assays (RIPA) ▪ ▪ ▪ oHIV-2 & Group O Test Viral Load CD4 Early Infant Diagnosis Viral Identification Market Segmentation by End User Diagnostic Laboratories Hospitals Research Institutes Others Market Segmentation by Region North America HIV Diagnosis Market • • • • • • • • • oBy product oBy type of test oBy end user oBy country – U.S. and Canada Europe HIV Diagnosis Market • oBy product oBy type of test oBy end user oBy country – Germany, U.K., France, Italy, Spain, and Rest of Europe Asia-Pacific (APAC) HIV Diagnosis Market • oBy product oBy type of test oBy end user oBy country – China, India, Japan, Australia, South Korea, and Rest of APAC Latin America (LATAM) HIV Diagnosis Market • oBy product oBy type of test oBy end user oBy country – Brazil, Mexico, and Rest of LATAM Middle East and Africa (MEA) HIV Diagnosis Market • oBy product 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. oBy type of test oBy end user oBy country – Saudi Arabia, South Africa, and Rest of MEA 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

6. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved